1. Home
  2. EQS vs VNRX Comparison

EQS vs VNRX Comparison

Compare EQS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

N/A

Current Price

$1.37

Market Cap

18.9M

Sector

Finance

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.14

Market Cap

22.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQS
VNRX
Founded
1991
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
22.5M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
EQS
VNRX
Price
$1.37
$0.14
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$1.67
AVG Volume (30 Days)
7.9K
6.0M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$355.66
Revenue Next Year
N/A
$849.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$0.74
$0.15
52 Week High
$2.49
$0.94

Technical Indicators

Market Signals
Indicator
EQS
VNRX
Relative Strength Index (RSI) 33.08 32.74
Support Level $1.27 N/A
Resistance Level $1.52 $0.31
Average True Range (ATR) 0.08 0.01
MACD -0.02 -0.00
Stochastic Oscillator 0.00 5.88

Price Performance

Historical Comparison
EQS
VNRX

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: